Gini Deshpande
Gründer bei NuMedii, Inc.
Aktive Positionen von Gini Deshpande
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
NuMedii, Inc.
NuMedii, Inc. Miscellaneous Commercial ServicesCommercial Services NuMedii, Inc. discovers and de-risks effective new drugs by translating Life Sciences Big Data into therapies. Its Big Data technology, originally developed at Stanford University, utilizes large amounts of scientific data together with proprietary biological network-based algorithms to discover drug-disease connections and biomarkers that are predictive of efficacy. The firm translates these predictions into novel de-risked drug candidates and partners with pharmaceutical companies for development and commercialization. The company was founded by Gini Deshpande, Joel Dudley and Atul J. Butte in 2008 and is headquartered in Palo Alto, CA. | Direktor/Vorstandsmitglied | 01.01.2008 | - |
Vorstandsvorsitzender | 01.01.2008 | - | |
Gründer | 01.01.2008 | - | |
Cathay Capital Private Equity SAS
Cathay Capital Private Equity SAS Investment ManagersFinance Cathay Capital Private Equity SAS (Cathay Capital PE) is a private equity firm founded in 2007 by Mingpo Cai and Edouard Moinet. The firm is headquartered in Paris, France. | Private Equity Investor | 01.01.2021 | - |
Karriereverlauf von Gini Deshpande
Ausbildung von Gini Deshpande
Purdue University | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 3 |
Frankreich | 2 |
Operativ
Director/Board Member | 1 |
Chief Executive Officer | 1 |
Founder | 1 |
Sektoral
Commercial Services | 2 |
Finance | 2 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
NuMedii, Inc.
NuMedii, Inc. Miscellaneous Commercial ServicesCommercial Services NuMedii, Inc. discovers and de-risks effective new drugs by translating Life Sciences Big Data into therapies. Its Big Data technology, originally developed at Stanford University, utilizes large amounts of scientific data together with proprietary biological network-based algorithms to discover drug-disease connections and biomarkers that are predictive of efficacy. The firm translates these predictions into novel de-risked drug candidates and partners with pharmaceutical companies for development and commercialization. The company was founded by Gini Deshpande, Joel Dudley and Atul J. Butte in 2008 and is headquartered in Palo Alto, CA. | Commercial Services |
Cathay Capital Private Equity SAS
Cathay Capital Private Equity SAS Investment ManagersFinance Cathay Capital Private Equity SAS (Cathay Capital PE) is a private equity firm founded in 2007 by Mingpo Cai and Edouard Moinet. The firm is headquartered in Paris, France. | Finance |
- Börse
- Insiders
- Gini Deshpande
- Erfahrung